ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 732

Long-Term Effect of TNF Inhibitors on Radiographic Progression in Ankylosing Spondylitis Is Associated with Syndesmophytes at Baseline and Time-Averaged CRP Levels

Maria Konsta1,2, Grigorios Sakellariou3, Alexios Iliopoulos4, PETROS P SFIKAKIS5 and I.E. Van der Horst - Bruinsma6, 1Amsterdam Rheumatology and Immunology Center,VUmc and Reade, Amsterdam, Netherlands, 2First Department of Propaedeutic and Internal Medicine, Laikon Hospital, Athens University Medical School, Greece, Athens, Greece, 3Rheumatology, Veterans Administration Hospital, Athens, Greece, 4Department of Rheumatology, Veterans Administration Hospital, Athens, Greece, 5First Department of Propedeutic Internal Medicine, Laikon Hospital, Athens University Medical School, Athens, Greece, 6GENRA Consortium, Amsterdam, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Ankylosing spondylitis (AS)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster I: Axial and Peripheral Spondyloarthritis – Clinical Aspects, Imaging and Treatment

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Although the radiographic progression in AS is associated with both baseline and time-averaged level of CRP in TNF naïve patients, the effect of level of acute phase reactants on radiographic progression in anti-TNF treated patients has not yet been investigated. The purpose of this study is to investigate whether the impact of long-term treatment with TNF inhibitors on radiographic progression in AS is associated with the level of acute phase reactants.

Methods: Seventy consecutive AS patients with long-standing anti-TNF treatment [47 men; age: 49 ± 11years (mean±SD); disease duration: 25 ± 12 years] were included in this retrospective study. Lateral X-rays of cervical and lumbar spine obtained before anti-TNF initiation were compared to those obtained after a period of 7±2.3 (range: 3-12) years. The levels of CRP and ESR were evaluated at least every 6 months. The radiographic damage was assessed by the mSASSS. New syndesmophyte formation or ΔmSASSS-score/year ≥1 unit/year was defined as radiographic progression. As ΔmSASSS-score/year was defined the difference between mSASSS at last visit and mSASSS at baseline, accounting for the time gap between radiographs. Mann-Whitney test was used to test for the differences in continuous variables between two groups, and Spearman’s coefficient was used for correlations between continuous variables. Additionally, logistic regression analysis was applied.

Results: Thirty-eight AS patients (54%) showed radiographic progression. ΔmSASSS score/year was positively correlated with baseline CRP (r=0.44, p=0.0001) and baseline ESR (r=0.35, p=0.004), as well as with time-averaged CRP (r=0.3, p=0.004). Furthermore, ΔmSASSS score/year was significantly greater (p<0.0001) in patients with syndesmophytes at baseline [1 (0.6-1.8), median (IQR)] compared to those without [0 (0-0.4)]. In multivariate logistic regression analysis, independent risk factors for spinal radiographic progression during anti-TNF treatment were the presence of syndesmophytes at baseline (OR: 9.8, CI: 3-33) and the time-averaged CRP >5mg/L (OR: 6.4, CI: 1.9-21).

Conclusion: In AS patients with long-term anti-TNF treatment, radiographic progression is associated with elevated levels of time-averaged CRP. Furthermore, patients with syndesmophytes at baseline have greater radiographic progression.


Disclosure: M. Konsta, None; G. Sakellariou, None; A. Iliopoulos, None; P. P. SFIKAKIS, None; I. E. Van der Horst - Bruinsma, Pfizer, MSD and AbbVie, 2,AbbVie, MSD, UCB, 5.

To cite this abstract in AMA style:

Konsta M, Sakellariou G, Iliopoulos A, SFIKAKIS PP, Van der Horst - Bruinsma IE. Long-Term Effect of TNF Inhibitors on Radiographic Progression in Ankylosing Spondylitis Is Associated with Syndesmophytes at Baseline and Time-Averaged CRP Levels [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/long-term-effect-of-tnf-inhibitors-on-radiographic-progression-in-ankylosing-spondylitis-is-associated-with-syndesmophytes-at-baseline-and-time-averaged-crp-levels/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/long-term-effect-of-tnf-inhibitors-on-radiographic-progression-in-ankylosing-spondylitis-is-associated-with-syndesmophytes-at-baseline-and-time-averaged-crp-levels/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology